Tadalafil Dosing for Erectile Dysfunction and Pulmonary Arterial Hypertension

Approved Dosing and Safety Considerations

• The American Urological Association guidelines recommend titrating PDE5 inhibitors to provide optimal efficacy while minimizing side effects 1
• For erectile dysfunction, tadalafil is FDA-approved at 5-10mg once daily or 20mg as needed (not daily) 1
• For PAH, tadalafil is approved at up to 40mg once daily 2, 3
• The dosing difference reflects the distinct therapeutic targets and safety considerations for each condition 4, 5
• Common adverse effects of tadalafil include headache, dyspepsia, back pain, myalgia, nasal congestion, flushing, and dizziness 1
• The risk-benefit ratio differs between PAH (life-threatening condition) and ED (quality of life condition) 4, 6

Clinical Practice and Efficacy

• PAH is a life-threatening condition requiring more aggressive treatment, justifying higher doses despite potential side effects 2, 4
• ED treatment focuses on quality of life with a more conservative risk-benefit approach 1, 7
• Regulatory approval reflects the different risk tolerances for these distinct conditions 5, 6

Daily Tadalafil Dosing Guidelines

Clinical Evidence and Recommendations

• The American Urological Association recommends 5 mg daily tadalafil as a treatment option for LUTS/BPH, particularly in men with comorbid ED 8, 9
• The European Association of Urology supports tadalafil 5 mg once daily for improving LUTS and erectile dysfunction 10, 11
• The maximum approved dose of daily tadalafil for pulmonary arterial hypertension is 40 mg once daily, as stated in the European Heart Journal 12